Twitter Logo Youtube Circle Icon LinkedIn Icon

China > Healthcare and life sciences > Healthcare and life sciences: PRC firms > Law firm and leading lawyer rankings


Index of tables

  1. Healthcare and life sciences: PRC firms
  2. Leading individuals
  3. Next Generation Partners

Leading individuals

  1. 1

Next Generation Partners

  1. 1

Fangda Partners' client roster is diversified, ranging from large and medium-sized pharmaceutical companies, medical device manufacturers, distribution groups, contract research organisations, to private equity funds and venture capitals. Among its recent mandates, Fang Qi represented Watson Pharmaceuticals in its infringement dispute with another international pharmaceutical company regarding patent for the treatment of Schizophrenia; Qi also advised APBI in a patent administrative case concerning the validity of its patent for Dapoxetine at the Beijing High Court and the Supreme Court. On the transactional side, Josh Shin and Yang Gao advised Astra Zeneca in its granting to China Medical System of exclusive commercialisation rights of Plendil in China. Shin and Diana Li also assisted Wuxi Biologics with its IPO at the HKEX and handled Everbright's share acquisition of Lifetech Scientific (Shenzhen) from Medtronics. Kate Yin is singled out for her expertise in handling compliance and regulatory matters as well as internal investigations.

Global Law Office's 'go-to' department excels in handling financing, M&A, reform and restructuring of public hospitals and regulatory mandates. The team, led by Alan Zhou, is a 'clear market leader in the healthcare and life sciences sphere' and is singled out for its 'fast response and commercially-minded advice'. Zhou 'fully understands the industry', and gives 'timely and operative response'. Coco Fan has notable knowledge in the medical, biopharmaceutical and animal health industries. Robert Sun, Michael Yu and David Fu are key names to note, as is anti-corruption specialist Jacky Li. The team acted as PRC counsel for BeiGene in its $1.4bn acquisition of Celgene China Entity, handled Siemens Healthineers' restructuring of China healthcare business and advised GP Health Service Capital on its RMB200m investment in Beaucare's series B financing. GlaxoSmithKline, ChunYu Doctor, Zeiss and Shanghai Pharmaceuticals also feature in its impressive client list.

King & Wood Mallesons is regularly instructed on the largest transactions in the China market; in 2017, the team advised LuyePharma Hong Kong on its purchase of Astra Zeneca's Seroquel and Seroquel XR in the UK, China and other 49 international markets and assisted a number of US and Chinese investors in the sales and purchases of pharmaceutical and medical devices companies. Other instructions include acting for an investment fund in financing for a medical device company and assisting a Chinese pharmaceutical company with compliance issues relating to the IPO approval by the Securities Regulatory Commission. The sizable group is led by transaction lawyers Jianping Wang and Jianwen Huang which also includes patent specialist Wenping Chen. Senior associate Yuanyuan Zhu is also a recommended practitioner with particular expertise in compliance and investigation.

Han Kun Law Offices is regularly instructed by major funds in their significant healthcare sector investments in China. It also handles compliance and regulatory issues and has particular expertise in competition law, IP and litigation. Among its recent highlights, the team assisted a global pharmaceutical company with a compliance investigation, and advised a dental service chain in a financing mandate. IP specialist Yan Wang represented SMTP Technology in a series of patent infringement and invalidation disputes against Sonicmed Medical Technology. Charles Li is recommended for public and private financing, corporate restructuring and IP protection; Shanghai-based Min Zhu and Kelvin Gao focus on the formation and deployment of private equity funds, M&A and corporate matters.

Zhong Lun Law Firm advises pharmaceutical companies and healthcare providers on corporate, securities and regulatory matters. The team also has experience handling IP disputes and licensing transactions, Shanghai-based Helen Cheng is a key name to note. Cheng recently represented a Chinese biotech company in defending two patent infringement cases filed by a foreign company at the Beijing Intellectual Property Court and assisted Chiral Quest (Suzhou) with a series of technology license agreements and a patent ownership dispute against Zhejiang Changming Pharmaceutical. Its recent transactional mandates including advising C-Bridge Capital on its financing for CMAB Biopharma and advised Shenzhen Hepalink Pharmaceutical Group on its share purchase of Shenzhen Topknow Industry and Development.

JunHe LLP specialises in major institutional investors mandates, with capability of handling regulatory, IP and contentious matters. The team includes Fan Yang who advises life sciences and healthcare sector clients as well as private equity funds; Xudong Tao whose expertise lies in the formation and restructuring of companies and private equity funds; and Feng Zhou who is experienced in handling high-profile M&A transactions. The team handled a number of M&A and joint venture mandates.

Llinks Law Offices leverages its strength in capital markets to advise on a mix of listing, financing and M&A transactions for multinational and domestic pharmaceutical clients; it also advises on IP protection, cybersecurity and data protection issues. The team assisted a consortium of institutional investors with their investment in Eyebright, a leading Chinese ophthalmic medical company, and advised Elemental Concept 2016 on cybersecurity and data protection issues in relation to the development, licensing, and operation of medical record system for hospitals in China. Wayne Chen and David Yu are names to note.

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in China

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to